Calcitonin Salmon Injection, Solution
Product Images NDC 25021-473

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Calcitonin Salmon (NDC 25021-473). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cal0d 0004 01)

Structural Formula (Cal0d 0004 01)
Chemical structure diagram representing the amino acid sequence of the peptide Calcitonin Salmon consisting of 31 residues, labeled with single-letter codes for each amino acid along with their position numbers.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cal0d 0004 02)

Package Label – Principal Display Panel – Vial Label (Cal0d 0004 02)
Label for Calcitonin Salmon Injection, USP Synthetic, 400 USP Units per 2 mL (200 USP Units per mL) in a 2 mL multi-dose vial. The product is for intramuscular or subcutaneous injection and is manufactured for Sagent Pharmaceuticals in Schaumburg, IL, made in India. Storage instructions indicate refrigeration between 2° to 8°C (36° to 46°F), with protection from freezing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.